2016 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012
12/14/16
Organovo Signs Exclusive Distributor Agreement With Cosmo Bio (Japan)
12/13/16
Organovo Presents First Preclinical Data on 3D Bioprinted Human Liver Tissues at TERMIS-Americas Meeting
12/07/16
Organovo to Present on December 14 in a Live Interactive Webcast at VirtualInvestorConferences.com
11/22/16
Organovo to Present at 28th Annual Piper Jaffray Healthcare Conference
11/14/16
Organovo to Present at 2016 Canaccord Genuity Medical Technologies & Diagnostics Forum
11/03/16
Organovo Announces Fiscal Second-Quarter 2017 Results; Company Affirms Full-Year Fiscal 2017 and Long-Range Outlook
11/01/16
Organovo Receives Strong Customer Response for ExVive Human Kidney Tissue Launch
10/24/16
Organovo Announces Release Date for Fiscal Second-Quarter 2017 Financial Results
10/20/16
Organovo Prices Approximately $25 Million Public Offering of Common Stock
10/19/16
Organovo Announces Proposed Public Offering of Common Stock
10/11/16
Organovo Announces Select Preliminary Second-Quarter 2017 Results; Company Updates Full-Year Fiscal 2017 Outlook
10/05/16
Organovo Introduces 3D Bioprinted Human Liver as Leading Therapeutic Tissue in Preclinical Development
09/13/16
Organovo and Collaborators Publish Data in Toxicological Sciences Demonstrating Power of 3D Bioprinted Human Liver Tissues in Modeling Drug-Induced Liver Injury Leading to Fibrosis
09/07/16
Organovo Announces Initiation of Commercial Contracting for ExVive Human Kidney Tissue
08/18/16
Organovo Appoints Two New Members to Board of Directors
08/04/16
Organovo Announces Fiscal First-Quarter 2017 Results; Company Affirms Full-Year Fiscal 2017 and Long-Range Outlook
08/02/16
Organovo Announces Appointment of Craig Kussman as Chief Financial Officer
07/26/16
Organovo to Begin Trading on Nasdaq Stock Market
07/20/16
Organovo on Track to Commercialize Kidney Tissue; Company Signs First Customer Orders for Kidney Tissue Early Access Program
07/14/16
Organovo Announces Release Date for Fiscal First-Quarter 2017 Financial Results
07/11/16
Organovo and Roche Researchers Publish Data Demonstrating Superiority of 3D Bioprinted Human Liver Tissues in Assessing Drug-Induced Toxicity
06/13/16
Organovo Collaborates With UCSF Team to Develop 3D Bioprinted Tissues for Skeletal Disease Research
06/09/16
Organovo Announces Fiscal Fourth-Quarter and Full-Year 2016 Results; Company Issues Full-Year Fiscal 2017 Outlook
05/23/16
Organovo Announces Release Date for Fiscal Fourth-Quarter 2016 Financial Results
03/10/16
Organovo and Its Customers Present Data Supporting 3D Bioprinted Liver Tissues for Drug Toxicity Testing and Liver Fibrosis Modeling
02/08/16
Organovo Announces Fiscal Third-Quarter Results; Company Updates Full-Year Fiscal 2016 Outlook and Affirms Long-Range Guidance
02/01/16
Organovo To Present On February 11 In A Live Interactive Webcast At VirtualInvestorConferences.com
01/19/16
Organovo Announces Release Date for Fiscal Third-Quarter 2016 Financial Results
01/19/16
Barry Michaels to Retire as Organovo Chief Financial Officer
01/13/16
Organovo Subsidiary Samsara Sciences Launches Commercial Operations
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet